Key facts
- Notable investors include Tech Incubator Program for Startup, Digital Healthcare Partners, Regent Partners (Seoul).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Medisby
- ·The full record, as it builds
Funding rounds
No funding rounds for Medisby are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Medisby
Developer of an AI-based medical device intended to provide rehabilitation treatment to patients with musculoskeletal disorders using a robotic arm. The company is currently operating in Stealth mode.
- Sector
- Healthcare
- HQ
- Seoul, South Korea
- Founded
- 2024
- Employees
- 3
- Ownership
- Privately Held (backing)
Medisby doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Medisby shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Medisby in its N-PORT filings yet. We sweep new filings monthly.